Skip to main content
Figure 5 | Cancer Cell International

Figure 5

From: Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)

Figure 5

Pharmacodynamics of (A) native rhArg1 and (B) pegylated rhArg1 on plasma arginine in rats. Sprague-Dawley rats were each injected i.p. with native or pegylated rhArg11. Plasma was collected at the indicated times, and arginine in each sample was determined by amino acid analysis. The data given as the means and 1 SD of 8 animals.

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us